{"name": "iPierian",
 "permalink": "ipierian",
 "crunchbase_url": "http://www.crunchbase.com/company/ipierian",
 "homepage_url": "http://www.ipierian.com/",
 "blog_url": "",
 "blog_feed_url": "http://www.ipierian.com/drupal/news-events/newsroom",
 "twitter_username": "iPierian",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "iPierian",
 "email_address": "info@ipierian.com",
 "phone_number": "650-872-4700",
 "description": "biotechnology company",
 "created_at": "Mon Sep 28 10:06:02 UTC 2009",
 "updated_at": "Tue Mar 26 09:49:44 UTC 2013",
 "overview": "\u003Cp\u003EWe are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson\u0026#8217;s, and other major unmet medical needs.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[142,
       99],
      "assets/images/resized/0006/0988/60988v1-max-150x150.png"],
     [[142,
       99],
      "assets/images/resized/0006/0988/60988v1-max-250x250.png"],
     [[142,
       99],
      "assets/images/resized/0006/0988/60988v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Nancy",
      "last_name": "Stagliano",
      "permalink": "nancy-stagliano",
      "image": null}},
   {"is_past": false,
    "title": "Director of Finance",
    "person":
     {"first_name": "Karen",
      "last_name": "C. Lam",
      "permalink": "karen-c-lam",
      "image": null}},
   {"is_past": false,
    "title": "Senior Director of Strategic and Corporate Development",
    "person":
     {"first_name": "Dr.",
      "last_name": "Adam Rosenthal",
      "permalink": "dr-adam-rosenthal",
      "image": null}},
   {"is_past": false,
    "title": "Board",
    "person":
     {"first_name": "Wesley",
      "last_name": "Chan",
      "permalink": "wesley-chan",
      "image":
       {"available_sizes":
         [[[150,
            100],
           "assets/images/resized/0008/6202/86202v2-max-150x150.jpg"],
          [[250,
            166],
           "assets/images/resized/0008/6202/86202v2-max-250x250.jpg"],
          [[450,
            300],
           "assets/images/resized/0008/6202/86202v2-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$43.2M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.biocetera.com/inthenews.php?id=121265",
    "source_description": "iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming",
    "raised_amount": 11500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 7,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MPM Capital",
         "permalink": "mpm-capital",
         "image":
          {"available_sizes":
            [[[150,
               142],
              "assets/images/resized/0004/5561/45561v1-max-150x150.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-250x250.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kleiner Perkins Caufield \u0026 Byers",
         "permalink": "kleiner-perkins-caufield-byers",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Highland Capital Partners",
         "permalink": "highland-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0001/0992/10992v7-max-150x150.jpg"],
             [[250,
               59],
              "assets/images/resized/0001/0992/10992v7-max-250x250.jpg"],
             [[450,
               106],
              "assets/images/resized/0001/0992/10992v7-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "http://deals.venturebeat.com/2009/10/26/ipierian-snags-3-7m-grant-from-nih-for-cell-reprogramming/",
    "source_description": "iPierian snags $3.7M grant from NIH for cell reprogramming",
    "raised_amount": 3700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 10,
    "funded_day": 1,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020100908e6990008d\u0026r=Rss\u0026s=DJFVLS",
    "source_description": "IPierian Announces Second Close Of Series B Financing At $28M  ",
    "raised_amount": 28000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 9,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Google Ventures",
         "permalink": "google-ventures",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0003/9829/39829v8-max-150x150.jpg"],
             [[250,
               116],
              "assets/images/resized/0003/9829/39829v8-max-250x250.jpg"],
             [[450,
               210],
              "assets/images/resized/0003/9829/39829v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Biogen Idec",
         "permalink": "biogen-idec",
         "image":
          {"available_sizes":
            [[[150,
               55],
              "assets/images/resized/0004/8826/48826v3-max-150x150.jpg"],
             [[206,
               76],
              "assets/images/resized/0004/8826/48826v3-max-250x250.jpg"],
             [[206,
               76],
              "assets/images/resized/0004/8826/48826v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mitsubishi UFJ Capital",
         "permalink": "mitsubishi-ufj-capital",
         "image":
          {"available_sizes":
            [[[150,
               23],
              "assets/images/resized/0002/9215/29215v3-max-150x150.jpg"],
             [[250,
               39],
              "assets/images/resized/0002/9215/29215v3-max-250x250.jpg"],
             [[332,
               53],
              "assets/images/resized/0002/9215/29215v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ATEL Ventures",
         "permalink": "atel-ventures",
         "image":
          {"available_sizes":
            [[[150,
               54],
              "assets/images/resized/0002/2872/22872v1-max-150x150.jpg"],
             [[250,
               90],
              "assets/images/resized/0002/2872/22872v1-max-250x250.jpg"],
             [[326,
               118],
              "assets/images/resized/0002/2872/22872v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MPM Capital",
         "permalink": "mpm-capital",
         "image":
          {"available_sizes":
            [[[150,
               142],
              "assets/images/resized/0004/5561/45561v1-max-150x150.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-250x250.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Highland Capital Partners",
         "permalink": "highland-capital-partners",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0001/0992/10992v7-max-150x150.jpg"],
             [[250,
               59],
              "assets/images/resized/0001/0992/10992v7-max-250x250.jpg"],
             [[450,
               106],
              "assets/images/resized/0001/0992/10992v7-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Kleiner Perkins Caufield \u0026 Byers",
         "permalink": "kleiner-perkins-caufield-byers",
         "image":
          {"available_sizes":
            [[[150,
               150],
              "assets/images/resized/0001/0998/10998v8-max-150x150.jpg"],
             [[250,
               250],
              "assets/images/resized/0001/0998/10998v8-max-250x250.jpg"],
             [[450,
               450],
              "assets/images/resized/0001/0998/10998v8-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.biocetera.com/inthenews.php?id=121265",
    "source_description": "iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming",
    "acquired_year": 2009,
    "acquired_month": 7,
    "acquired_day": 8,
    "company":
     {"name": "iZumi Bio",
      "permalink": "izumi-bio",
      "image":
       {"available_sizes":
         [[[123,
            120],
           "assets/images/resized/0004/1142/41142v1-max-150x150.png"],
          [[123,
            120],
           "assets/images/resized/0004/1142/41142v1-max-250x250.png"],
          [[123,
            120],
           "assets/images/resized/0004/1142/41142v1-max-450x450.png"]],
        "attribution": null}}}],
 "offices":
  [{"description": "HQ",
    "address1": "951 Gateway Blvd.",
    "address2": "",
    "zip_code": "94080",
    "city": "South San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        121],
       "assets/images/resized/0006/0989/60989v1-max-150x150.jpg"],
      [[250,
        202],
       "assets/images/resized/0006/0989/60989v1-max-250x250.jpg"],
      [[450,
        364],
       "assets/images/resized/0006/0989/60989v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}